Boothbay Fund Management, LLC Lyra Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

$3.6 Billion
Q3 2024

A detailed history of Boothbay Fund Management, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 232,670 shares of LYRA stock, worth $44,207. This represents 0.0% of its overall portfolio holdings.

Number of Shares

232,670

Previous 232,670 -0.0%

Holding current value

$44,207

Previous $65,000 7.69%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.55 - $6.53 $78,573 - $112,766	-17,269 Reduced 6.91%	232,670 $1.45 Million
Q4 2023 Feb 14, 2024	BUY	$2.82 - $5.24 $44,939 - $83,504	15,936 Added 6.81%	249,939 $1.31 Million
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $207,467 - $337,574	70,328 Added 42.97%	234,003 $914,000
Q2 2023 Aug 14, 2023	BUY	$1.98 - $4.33 $255,328 - $558,370	128,954 Added 371.4%	163,675 $672,000
Q3 2022 Nov 14, 2022	SELL	$4.95 - $6.6 $18,082 - $24,109	-3,653 Reduced 9.52%	34,721 $174,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $7.51 $585 - $1,066	-142 Reduced 0.37%	38,374 $217,000
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $2,886 - $6,436	-684 Reduced 1.74%	38,516 $168,000
Q3 2021 Nov 15, 2021	SELL	$6.06 - $9.43 $266,367 - $414,495	-43,955 Reduced 52.86%	39,200 $358,000
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $3,420 - $6,232	-495 Reduced 0.59%	83,155 $668,000
Q1 2021 May 17, 2021	SELL	$10.38 - $15.61 $38,437 - $57,803	-3,703 Reduced 4.24%	83,650 $970,000
Q4 2020 Feb 12, 2021	BUY	$9.28 - $13.88 $405,433 - $606,403	43,689 Added 100.06%	87,353 $996,000
Q3 2020 Nov 16, 2020	BUY	$10.61 - $13.96 $463,275 - $609,549	43,664 New	43,664 $488,000

Others Institutions Holding LYRA

# of Institutions

Shares Held

32M

Call Options Held

21.1K

Put Options Held

400

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.05M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Lyra Therapeutics, Inc. Transaction History